Effect of Pain on Quality of Life in Patients with Parkinson's Disease
Abstract
Objective: To analyze the impact of pain on the quality of life of patients with Parkinson's disease. Methods: 200 patients with primary Parkinson's disease admitted in the Shaanxi Provincial People's Hospital from August 2019 to November 2020 were selected for the experiment, and these patients were divided into pain group and non-pain group in turn. Among them, there were 98 patients in the pain group and 102 patients in the non-pain group. King's Parkinson's disease pain scale was used to evaluate the severity and type of pain, and then ess and HAMD-17 were used to evaluate patients' depression and daytime sleepiness. Results: the incidence of pain in patients with Parkinson's disease was about 49%, including 38% of wave related pain and 74% of musculoskeletal pain. The score of quality-of-life Scale-39 in the pain group was higher than that in the non-pain group, and the difference was statistically significant (P < 0.01). Conclusion: musculoskeletal pain is a common type of pain in patients with Parkinson's disease, followed by nocturnal pain and fluctuation related pain. Its pain will have a direct impact on the quality of life of patients with Parkinson's disease.
References
[2] Gao QR, Ye QY, Chen XC. Analysis of non-motor symptoms of Parkinson's disease with REM sleep behavior disorder [J]. Chinese Journal of neuroimmunology and neurology. 2018 (05).
[3] Zhang YJ, Zhang ZG, Zhang RY. Comparison of non-motor symptoms in patients with early and middle and late Parkinson's disease [J]. Modern medicine and health. 2018 (12).
[4] Feng WR, Liu WG. Follow up study on non-motor symptoms in patients with Parkinson's disease [J]. Chinese Journal of geriatrics. 2014 (12).
[5] The burden of non-motor symptoms, mood and gait disorders are the most important factors leading to the decline of quality of life in non-dementia patients with Parkinson's disease [J]. Chinese Medical Journal.2020 (27).
Copyright (c) 2022 Yue Liu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.